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Innovations Research Area, Bambino Gesù Children’s Hospital, Rome, ItalyA B S T R A C TObjectives: This article outlines the Decision-Oriented Health Tech-
nology Assessment: a new implementation of the European net-
work for Health Technology Assessment Core Model, integrating
the multicriteria decision-making analysis by using the analytic
hierarchy process to introduce a standardized methodological
approach as a valued and shared tool to support health care decision
making within a hospital. Methods: Following the Core Model as
guidance (European network for Health Technology Assessment. HTA
core model for medical and surgical interventions. Available from:
http://www.eunethta.eu/outputs/hta-core-model-medical-and-surgi
cal-interventions-10r. [Accessed May 27, 2014]), it is possible to apply
the analytic hierarchy process to break down a problem into its
constituent parts and identify priorities (i.e., assigning a weight to
each part) in a hierarchical structure. Thus, it quantitatively compares
the importance of multiple criteria in assessing health technologies
and how the alternative technologies perform in satisfying these
criteria. The verbal ratings are translated into a quantitative form by
using the Saaty scale (Saaty TL. Decision making with the analy-




ndence to: Matteo Ritrovato, Viale Ferdinando Baldanalysis is used for deriving the weights’ systems (i.e., local and global
weights’ system) that reﬂect the importance assigned to the cri-
teria and the priorities related to the performance of the altern-
ative technologies. Results: Compared with the Core Model, this
methodological approach supplies a more timely as well as contex-
tualized evidence for a speciﬁc technology, making it possible to
obtain data that are more relevant and easier to interpret, and
therefore more useful for decision makers to make investment
choices with greater awareness. Conclusions: We reached the con-
clusion that although there may be scope for improvement, this
implementation is a step forward toward the goal of building a “solid
bridge” between the scientiﬁc evidence and the ﬁnal decision maker’s
choice.
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Health technology assessment (HTA) arises in answer to the
unchecked spread of expensive health technologies (HTs). HTA is
a multidisciplinary assessment process aimed at supporting
decisions pertaining to the allocation of resources [1]. This is
especially in view of the fact that the health system has limited
resources, which cannot satisfy all the health demands of a
population with a trend toward increasing health needs owing to
progressive aging and an enhanced awareness of the availability
and potential of new HTs. As a matter of fact, HTA is not a mere
research tool, but rather a systematic, rigorous, reproducible
assessment process that can be considered a “bridge between
the world of research and the world of decision making, partic-
ularly policy making” [1]. In view of this, HTA becomes a
governance approach aimed at linking decisions to availablescientiﬁc evidence. This metaphor, often referred to over the
years, might well become rhetorical if we cannot deﬁne more
accurately what connects each end of the “bridge”: the start (e.g.,
available scientiﬁc evidence) and ﬁnish points (i.e., decision by
health care managers and policymakers) are clearly deﬁned, but
the pathway connecting who produces the evidence and the ﬁnal
decision makers (that is to say, the standardized methodology of
gathering and reporting evidence on the basis of which the
decision makers make their choices) is still inaccurate and
elusive. One of the main reasons for the gap between the
available scientiﬁc evidence and the evidence needed by decision
makers is the failure to provide decision makers with more
efﬁcient and suitable (in other words, appropriate) tools (because
they permit a decision in an effective and timely way and take
into account all the relevant aspects), enabling them to make a
more knowledgeable decision between the different alternatives.ociety for Pharmacoeconomics and Outcomes Research (ISPOR).
elli n.41 00146, Rome, Italy.
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answers to the questions raised by decision makers. This is even
more often the case at the “meso” level—that is to say, when it is
necessary to establish whether a technology should be imple-
mented within a hospital, while at the same time trying to
forecast the possible impact on its organizational frame. In fact,
especially in the case of particularly innovative technologies,
while the scientiﬁc literature focuses on aspects such as safety
and clinical efﬁcacy, hospital managers need to also take into
account organizational and economical aspects as well as tech-
nical or legal implications.
The application of HTA methodology at the meso level [2], and
in particular its implementation at the hospital level (deﬁned as
hospital-based HTA) [3], is essential when considering the adop-
tion or rejection of HTs in a hospital because it is aimed at
contextualizing both evidences and decisions. The hospital-based
HTA is a hospital assessment process for using the available
evidence in decision-making processes about the introduction of
new or existing technology. Differences in how HTA is perceived,
understood, or used in the national or regional health care setting
may have an important impact on the way HTA methodology is
organized and used within a hospital.
Hospitals should not each implement their own detailed
methodology usable only within their organization and suitable
only for a limited set of technologies; rather, a standardized
methodology that can be applied to all the available technologies
and, if possible, be shared among all HTA specialists (hence
overcoming barriers in the collaboration of HTA assessment
among hospitals) must be structured. Decision makers do not
have the time and resources needed for developing an exhaustive
HTA program, and, therefore, they require suitable tools for
facilitating the adaptation of HTA output from external reports,
making their ﬁnal choice easier [4]. Moreover, because decision
makers often take into consideration what is being done in other
systems or in other countries, it is desirable to reach stand-
ardized outputs to assess the HT impact at its different levels by
means of a shareable and adaptable method to each health
context (national, regional, local) or health care organization.
In 2004, the European network for Health Technology Assess-
ment (EUnetHTA) was established by the European Commission
and Council of Ministers to create an effective and sustainable
network for HTA across Europe and help to develop reliable,
timely, transparent, and transferable information to contribute to
HTAs in European countries. As part of its mission, the EUnetHTA
developed the Core Model, a methodological framework for
shared production and sharing of HTA information. Although
the Core Model is conﬁrmed as an accurate and important guide
for the assessment of an emerging technology, it has some limits.
These limits are found especially when it is applied within a
hospital context (the meso level [3]): speciﬁcally, its implementa-
tion would lead to results that would be difﬁcult to understand
and could not be easily or immediately applied. In fact, the
literature results, which are the outcome of analyses carried out
by colleagues who have previously tested the applicability of the
Core Model [5–7], consist mainly of lists of answers (i.e., “issues”).
Despite being important and indicative of the technology under
consideration, these do not provide a tangible understanding of
how the decision maker will then decide whether to adopt a
given technology. Moreover, although the EUnetHTA Core Model
becomes more speciﬁc and detailed when it comes to operation-
alizing the questions pertaining to a given technology, the
purpose of such questions is often not applicable to the decision
makers’ needs and unlikely to point out the data of the evalua-
tion context.
Furthermore, asking a health organization (HTA multidiscipli-
nary team as well as every unit that conducts HTA) to answer
about 200 questions (such as those posed in the EUnetHTA CoreModel) would require a great amount of resources (in terms of
both cost and time). This is, however, necessary to comply with
the accuracy and time constraints of the Hospital Management/
Board of Directors or of the HTA project’s sponsor. An HTA report
previously elaborated by other institutions (though compliant
with the Core Model) could not be shared among different levels
(national, regional, local) or organizations because it is usually
not reported in a deﬁned, standardized, and structured output.
Actually, between the presentation of results based on the Core
Model guidelines and the ﬁnal decision, there is a gap that could
be bridged by carrying out further analyses and using models that
would allow the assessment to be concluded by deﬁning a
classiﬁcation of the assessed alternatives.
In view of this, the HTA Research Unit of the Bambino Gesù
Children’s Hospital in Rome, Italy, devised the Decision-Oriented
Health Technology Assessment (doHTA) method to guide and
support the introduction of innovative HTs in hospitals. The
doHTA is a new implementation of the EUnetHTA Core Model
that integrates multicriteria decision analysis (MCDA) by using
the analytic hierarchy process (AHP). Although key parts of the
Core Model remained substantially unaltered, the new approach
considers the repositioning of “domains,” “topics,” and “issues,”
redeﬁning them in a new goal-oriented framework [8]. It has been
developed to introduce a standardized methodological approach
as a valued and shared tool to support health care decision
making within a hospital. The aims of this article were 1) to
illustrate a detailed new implementation of the EUnetHTA Core
Model by also describing the main features of the AHP approach
in a hospital context and 2) to explain how the results of the
doHTA application can closely support health care decisions. No
previous analysis has shown the results of the integration
between AHP methodology and the Core Model application as a
part of the HTA process within a hospital setting.Methods
The EUnetHTA Core Model
The EUnetHTA Core Model has been devised mainly to promote
the standardization of HTA results, usable in all member states of
the European Union, to spread and share evidences and results
obtained. The EUnetHTA Core Model is built to focus on assess-
ment elements that describe the technology or the consequences
of its use in order to supply the information needed to decide on
the use or nonuse of any selected technology [9]. The model
combines several methods of analysis developed within each
discipline involved: epidemiology, cost-effective analyses, safety
and technical assessment, social science, ethics, and so forth.
The model aims to accurately organize the collected evidence
about the technology considered in different “assessment ele-
ments” made up of domains (i.e., health problem and current use
of technology, technical characteristics of the technology, safety,
clinical effectiveness, costs and economic evaluation, ethical
analysis, organizational aspects, social aspects, legal aspects),
topics, and issues [5,10]. Each assessment element “deﬁnes a
piece of information that describes the technology or the con-
sequences or implications of its use” [9].
Given the substantial differences between the domains listed
above, the nature of assessment elements can therefore differ
considerably because of the methods of investigation and anal-
ysis adopted to study each of them. Each domain is composed of
different topics, and each topic can concern more than one
domain. The topics represent more speciﬁc aspects within the
domain and can, in turn, be described by one or more issues. An
issue underlies a speciﬁc factor within a topic. This combination
accurately organizes the collected evidence about the technology
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thesized in a document (i.e., HTA full-report), with its form (e.g.,
structure and size) depending on the information goal and the
health system level at which the decision is to be made.
The availability of such a tool leads to an increase in the use of
HTA and its application as a support to decision-making proc-
esses [9,11]. The standardization of information in an HTA report
increases the clarity of information, enhances the quality and
thoroughness of information, fosters the extraction of items of
information from HTA reports as well as information sharing,
and reduces work duplication [9]. After the “prioritisation and/or
commissioning process” [12] (needed to establish which technol-
ogy investments should be made and, subsequently, which
technologies are to be assessed), the Core Model could be used
as an applicable tool for assessing HTs, as already frequently
happens in the European context. In fact, across Europe, it
represents an important standard tool for technology assessment
by which reliable, transparent, and transferable data about
selected technologies can be outlined and taken up into
decision-making processes.
Several studies have been carried out to test the Core Model at
performing HTA about a speciﬁc technology, such as multislice
computed tomography in coronary angiography or drug-eluting
stents [6,7]. The HTA on multislice computed tomography reveals
some weaknesses in the content of the assessment elements
(e.g., description and technical characteristics of technology,
accuracy). Indeed, some issues remain unanswered and some
answers are incomplete [7]. Despite this, the results of these
studies conﬁrm that the EUnetHTA Core Model is an appropriate
tool to produce HTA reports to support decision making and to
promote collaboration and sharing in HTA regarding the distri-
bution of results and the exploitation of the information pool
used in the assessment of the selected technologies.
The AHP
The AHP is an MCDA technique developed at the Wharton School
of Business by the mathematician Thomas Saaty in the 1970s
[13]. It is a method, already generally validated for MCDA,
deriving from operations research and is a valuable tool to help
decision makers in assessing HTs according to a ﬁnite number of
criteria. It is commonly used to break down a decision problem
into its constituent parts, which are then structured into a
hierarchy [14], combining a goal at the topmost level, criteria at
the consecutive level, and subcriteria at successive sublevels,
while the lowest level contains the alternatives. The AHP
includes a structured hierarchy, pairwise comparisons, verbal
ratings, experts’ judgments, an eigenvector method for deriving
weights, and a method to verify the “consistency” of judgments.
Indeed, the pairwise comparisons expressed in verbal form using
the Saaty scale [14] (e.g., “safety” is more important than “the
legal aspects” for the technology in question) are converted in a
consistent way into a set of numbers representing the relative
priority of each criterion. As a result, the AHP delivers a ranking
of alternatives that facilitates the selection of a policy option.
This technique for MCDA is increasingly being used and provides
valuable support in complex health care decisions [15].
The DoHTA Method
The doHTA method aims at integrating into a single consistent
tool the two above-mentioned methodologies and essentially
consists of the following main steps.
Step 1: Problem Deﬁnition
Using the EUnetHTA Core Model as guidance, determine the kind
of knowledge sought. This means identifying which speciﬁc“assessment element” may bring a piece of knowledge that can
potentially (if compliant with the above-mentioned eligibility
criteria) be translated into an indicator of the decisional structure.
Step 2: Literature Review
Scientiﬁc evidence should be obtained using major databases and
search engines, Web sites of national and international HTA
agencies, technical reports, clinical guidelines, primary studies,
systematic reviews, gray literature, documentation by technology
vendors/manufacturers, and information by clinicians, nurses,
and patients. The search strategy should include speciﬁc key
words and explicit MESH terms. The search should be focused on
studies that supply evidence of feasibility, safety, efﬁcacy, costs,
and organizational and technical characteristics of this technol-
ogy and on studies that compare this given technology with its
alternatives.
Step 3: Hierarchy Construction
The main goal of the literature review, among other objectives
such as acquiring a deeper knowledge of the question under
examination and gathering scientiﬁc evidence on HTs’ imple-
mentation outcomes, is to identify all the components of the
decisional hierarchy structure (i.e., the different key performance
indicators [KPIs]) and, in agreement with the AHP method, their
topological arrangement within it. Figure 1 presents an example
of the application of the doHTA method in the assessment of a
surgical robot: it highlights the decision tree structure, its nodes
and leaves, as well as the complete list of KPIs. Therefore, the
goal of the decision (which could be “the choice to adopt or not
adopt a high-cost innovative technology”) is broken down into its
constituent parts from the topmost level (the overall goal itself),
then the objectives from a broad perspective, and through the
intermediate levels representing ever more speciﬁc objectives.
Following the overall goal, the ﬁrst level is made of the criteria on
which subsequent elements depend [14]. In our model, the ﬁrst
level is made of the different domains singled out in the Core
Model; that is, each criterion is exactly identiﬁed by the “domain”
singled out in the Core Model. The sublevels are built by following
speciﬁc guidelines from the Core Model (i.e., questions depicted
as a topic or an issue and pertaining to a speciﬁc domain) yet
consisting of a list of detailed indicators (Level 1 KPIs and Level 2
KPIs). Level 1 KPIs and Level 2 KPIs represent well-deﬁned,
speciﬁc characteristics of the considered HT, resulting from the
synthesis of scientiﬁc evidence, the results of the speciﬁc context
analysis, and the application of the following eligibility criteria:1. KPIs must be “a priori” assessable.
2. KPIs are pertinent to all the alternative technologies under
consideration.
3. KPIs should preferably be objectively measurable.
Step 4: Priority Analysis
Lists of pairwise comparisons of indicators grouped under the same
nodes must be drawn and subsequently submitted to each profes-
sional participating in the assessment, who has to answer on the
basis of his or her own experience and knowledge. That is, for each
pair of elements in the pairwise comparison, each professional is
required to give a “verbal rating” to the elements compared by
responding to a question such as “How important is the element A
(e.g., ‘safety’) relative to the element B (e.g., ‘legal aspects’)?”
Each element in an upper level is used to compare the
elements in the level immediately below with respect to it [14].
Verbal ratings are translated into a quantitative form by using the
Saaty scale [14]. Given that the comparisons are accomplished
through personal or subjective judgments based on personal
Fig. 1 – Decisional tree. EUnetHTA domains and KPIs arranged into a hierarchical decision tree. EUnetHTA, European network
for Health Technology Assessment; KPI, key performance indicators.
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 5 0 5 – 5 1 1508knowledge (yet usually based on literature evidence) and experi-
ence, some degree of inconsistency may be observed [16]. There-
fore, at the end of each interview, it is desirable to check the
degree of consistency among the pairwise comparisons, and to
repeat the pairwise comparisons while trying to improve the
coherence of the judgments if it is found that the consistency
ratio exceeds the limit [17]. A consistency check is then per-
formed, as well as the computation of both local weights(i.e., the weights characterizing indicators with respect to the
connected upper node) and global weights (i.e., with respect to
the overall assessment goal), as stated in the AHP theory, by
means of eigenvectors analysis [14]. After pairwise comparisons
performed by all involved professionals are positively checked for
consistency, the derived weights’ systems are then averaged
using the geometric mean to yield a uniﬁed weights’ system
(Fig. 2).
Fig. 2 – Weights’ system. Example of the uniﬁed weights’
system (as relating to the ﬁrst layer of decisional tree).
Fig. 3 – Comparison of three alternative technologies. The
histogram chart highlights the contribution of each domain
to ﬁnal comparison between alternative technologies.
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With step 4 completed, a weighted decision tree is available for
evaluating the considered alternative technologies. This is per-
formed for a single technology by attributing to each lowest
indicator (i.e., the end nodes of the decision tree) a value
representing the performance of the technology with respect to
the indicator itself. Values to be attributed to each indicator vary
correspondingly according to its nature: some indicators can be
metrically estimated (e.g., spatial resolution, image uniformity,
power, and turnaround time), some by means of an estimate of
coverage of needs (e.g., percentage of laboratory tests performed
by a chemical analyser out of the hospital tests’ demand), some
by a true/false statement (e.g., the presence, or lack thereof, of a
speciﬁc characteristic of the technology, such as a failsafe valve
in an anesthesia machine), and some only by a qualitative
judgment scale of performance (i.e., attributing a “value” ranging,
e.g., from “very poor” to “excellent” to the performance of the
technology with respect to the indicator). The latter case, how-
ever, can be better accomplished by again following the AHP
theory, thus using alternative technologies to set up another
pairwise comparison list in which each technology is compared
against its alternative with respect to every lowest indicator.
Whatever the nature of the indicators, it is ﬁnally possible to
compute (by means of a weighted sum) a numerical value that
represents the performance of each technology with respect to
the overall decision goal. Moreover, exploiting the very character-
istics of the AHP method, it is also possible to compare alter-
native technologies’ performances with respect to lower levels
nodes (i.e., domains as well as sublevels indicators).
Step 6: Results Presentation
The results from the aggregation of values can then be repre-
sented either in graphical form (e.g., histogram and ring plot;
Fig. 3) or by numerical report, which are supposedly useful to
summarize the evidence that emerged from the evaluationprocess. Finally, each technological alternative is evaluated
against the lowest indicators (i.e., the end nodes in the hierarch-
ical tree) to derive an overall rating.Results
The doHTA method, already used and tested on a large number
of HTs since 2009 to reduce the above-mentioned gap, takes a
step forward by introducing a new implementation of the
EUnetHTA Core Model using the AHP. This allows for the out-
lining of the “general problem” into a number of subgoals and, for
each of these, makes it possible to compare and classify the
different solutions (i.e., alternative HTs) taken into account.
Then, the outcomes of each comparison can be combined back-
ward to the solution of the general problem. This is due, indeed,
to the various relevant features and points of view that typically
characterize such kinds of decisional problems, making it
intrinsically impossible to synthesize it into a single consis-
tent goal.
The domains making up the Core Model are all substantially
important and are therefore analyzed when a new technology is
assessed. What differentiates our new implementation of the
model from the original one is the possibility of streamlining the
assessment not only by selecting some topics and the related
issues but also by choosing the most characteristic features of the
technology to be assessed or through unifying some of these, and
hence gathering the meaning of topics and issues in a concise
ﬁnal element. To integrate the AHP method, the assessment
elements are translated in the form of criteria or subcriteria [17],
which we called KPIs. This means that selected topics and issues
are ﬁnally translated into a list of speciﬁc and narrow elements.
This new implementation confers a key role in ﬁnding evidence
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attribute a value for them that represents the performance of
the alternative technologies being considered (especially for
those KPIs that are already supported by strong literature evi-
dence, hardly leaving room for interpretation).
For instance, as regards the assessment of the robotic surgical
system within our hospital, several assessment elements were
identiﬁed, translated into KPIs, weighted, and arranged in a
decision tree (see Fig. 1). It was then possible, in the subsequent
comparison phase (see step no. 5), to attribute them a value
representing the performance of robotic surgery compared with
its conventional alternatives (laparoscopic surgery and open
surgery). If we look at one of the KPIs for the surgical robot
assessment regarding the analysis of safety aspects, “perioper-
ative blood loss” is one of several KPIs identiﬁed (because the
scientiﬁc literature places great relevance on this element). The
scientiﬁc literature has, in this speciﬁc case (for other evaluation
aspects, such as those related to organizational issues, internal
data have been the most relevant source), also been the primary
source considered while attributing a performance value (thus
attributing less perioperative bleeding to robotic and laparoscopic
surgeries, i.e., better performance values). If no strong evidence is
available, one should try to quantify KPIs through data from
hospital management systems, team expertise, feedback from
the stakeholders involved, face-to-face interviews, question-
naires, and so forth.
An example of the results achievable with this method is
presented in Figures 1, 2, and 3, all pertaining to the assessment of
a robotic surgical system. The ﬁrst one represents the decisional tree
that we have derived, in which EUnetHTA domains (corresponding
to the ﬁrst hierarchy level) and KPIs are arranged: 1) the apex is “the
assessment of a robotic surgery program within the pediatric
hospital”; the ﬁrst level is made of the different domains, such as
safety, clinical effectiveness, costs and economic evaluation, techni-
cal characteristics of the technology, ethical and social aspects, legal
aspects, and organizational aspects; the sublevels are built identify-
ing the Level 1 KPIs with respect to every previous criterion (e.g.,
safety: perioperative safety, postoperative safety, and technology-
related risks; technical characteristics of technology: technological
features, technical management). The later indicators (Level 2 KPIs)
are, for instance, “time of operation,” “perioperative blood loss,”
“postoperative length of hospital stay,” “surgical site infection,” “30-
day mortality rate,” “request of home postdischarge care,” “technol-
ogy-related risks for patients,” “surgeon’s ergonomics,” “mainte-
nance service,” “organizational downtime drawbacks,” “possible
impact on waiting lists,” “delta of contribution margin,” “breakeven
point,” “training programs and credentialing & privileging protocols,”
and “problems pertaining to the full comprehension of the informed
consent.” In this case, any hospital manager could use such a
decisional hierarchy structure to make choices about robotic surgery
investment, possibly by modifying a part of it (e.g., it could be
necessary to readjust some KPIs with respect to the individual
context).
The second ﬁgure speciﬁes the uniﬁed weights’ system as
related to the domains layer of the decisional tree, as derived
from pairwise comparisons and mathematical calculations in
accordance with the AHP method; in our study, about two thirds
of the whole evaluation is represented by safety and clinical
effectiveness. The doHTA method can provide similar charts for
each sublevel of the decisional tree. The histogram chart, illus-
trated in Figure 3, speciﬁes the computed performance (global
and per domain) of the available alternatives in Figures 1, 2, and 3
(robotic surgery, laparoscopic surgery, and open surgery, respec-
tively). Speciﬁcally, the computed performance (expressed in
terms of percentages as required by the AHP method) of alter-
native 1 is calculated as 28.14% for safety and 20.06% for clinical
effectiveness, with the others combined accounting for a verysmall percentage (i.e., 0.86%, cost and economic evaluation;
5.93%, technical characteristics of technology; 1.91%, organiza-
tional aspects; 2.01%, legal aspects; and 1.80%, ethical and social
aspects). As for the comparison between alternatives 1 and 2 (i.e.,
robotic surgery and laparoscopic surgery), the percentages for
safety and clinical effectiveness seem to be comparable, but the
“organizational aspects” are exclusively positive for laparoscopic
surgery. With regard to the “economic aspects,” as evidenced also
from the literature review, the results conﬁrmed the disadvan-
tages of robotic surgery, mainly due to the high initial cost and
the maintenance cost of the system.Conclusions
This article identiﬁed several key points of the doHTA method,
derived from the new implementation of the EUnetHTA Core
Model along with the AHP application, arising from its successful
implementation as a tool for effective and efﬁcient decision
making. Since 2009, many HTs have been analyzed by adopting
this new methodological approach within the Bambino Gesù
Children’s Hospital (e.g., blood gas analyzers [18], pulse oxi-
meters, the design/organizational structure of the clinical chem-
istry laboratory, and robotic pediatric surgery). In fact, we have
been able to supply a more precise and more structured output as
well as a contextualized evidence of speciﬁc technology, making
it possible to obtain data that are more relevant and easier to
interpret, and therefore more useful for the decision makers to
make investment choices with greater awareness.
The EUnetHTA Core Model has been an essential and proﬁt-
able guide for the implementation of our methodology for
supporting decision making by describing a framework for
identifying the different types of questions suitable to give
appropriate answers about the technology considered. It can also
guide HTA teams in selecting which aspect of a technology or its
use they could (or should) study. Yet, compared with the
EUnetHTA Core Model, the doHTA application provides a more
detailed and precise evidence to support the decision-making
process, summarizing each result in a standardized and struc-
tured output that can be shared and then used systematically by
other health care organizations. In fact, our method allows for
the identiﬁcation (in a very explicit fashion) of all the compo-
nents of the decisional hierarchy structure (i.e., KPIs) as well as
their topological arrangement and their weights within it. More-
over, the performance of each assessed HT is also appraised in a
straightforward and clear way. Thus, the result can then be used
(or readapted) by decision makers or HTA specialists from other
hospitals to assess the same or similar technologies by1. adopting the same hierarchy structure, as well as adding or
eliminating some KPIs (thus deriving a decision tree that
includes all the elements that are important in their context);2. adopting the same weights systems, as well as deriving (by
means of pairwise comparisons and AHP equations) their own
weights’ system (i.e., one that reﬂects more consistently their
opinion of which elements are of importance in their
context); and3. comparing different alternative technologies by attributing
performance value (relating to the single KPI) that is “meas-
ured” against context-speciﬁc requirements or characteristics.
Such a method, however, presents a potential operative
criticality. In fact, because the interviewees have different com-
petences and roles (i.e., belonging to different professional and
expertise areas), a simplistic application of the geometric mean
as per the computation of the global weights’ system can lead to
a biased evaluation because of the possible imbalance of experts
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professional with respect to his or her professional area, comput-
ing a weights’ system for each professional area, and then
computing the global weights’ system as a geometric mean of
the weights’ system of different professional areas.
We have tested the doHTA method on various HTs (from
hospitalwide services to multipurpose tools to much specialized
devices) to check its feasibility, adaptability, and scalability. Our
method allows a structured and more precise output, giving decision
makers the possibility to choose more knowingly between the
different considered alternatives, often in a very short time (as they
have been provided with a clear and instantaneous depiction of the
whole evaluation, making their ﬁnal choice easier and faster).
Thus, we have reached the conclusion that although there may
be scope for improvement, this implementation is a step forward
toward the goal of building a “solid bridge” between the available
scientiﬁc evidence and the ﬁnal decision maker’s choice.
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